AI-ECG Tracker vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-ECG Tracker

by Carewell Health

EchoGo Pro

by Ultromics

AI Verdict

Tool A, AI-ECG Tracker, specializes in AI-powered auto-diagnosis of various cardiac abnormalities using ECG data, offering flexible on-premise and optional cloud deployment. Conversely, Tool B, EchoGo Pro, focuses on AI-driven analysis of stress echocardiography to diagnose coronary artery disease, delivered as a cloud-based SaaS solution. While both leverage AI to enhance cardiac diagnosis, they utilize distinct diagnostic modalities and target different specific cardiac conditions.

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your primary need is rapid, highly accurate, and comprehensive AI-powered auto-diagnosis of 12-lead ECGs for a wide range of cardiac abnormalities, including arrhythmias and myocardial events. This tool is ideal for environments requiring on-premise processing power for quick, detailed ECG interpretation, with the flexibility of optional cloud services for remote diagnostics.

View AI-ECG Tracker →

Choose EchoGo Pro if…

Choose EchoGo Pro if your focus is on automating and enhancing the analysis of stress echocardiography to improve the diagnosis of coronary artery disease. This cloud-based, vendor-neutral solution is best suited for healthcare providers seeking a near-instant, accurate, and easily integrated system that requires no software installation and seamlessly fits into existing PACS and clinical workflows.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-ECG Tracker	EchoGo Pro
Pricing	Unknown	Contact vendor for pricing
Deployment	Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.	Cloud-based
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro (Tool B) offers superior usability due to its cloud-based SaaS model, requiring no software installation or extensive training, and providing a 'zero-click, full automation workflow' for seamless integration with existing clinical systems like PACS, DICOM, and HL7. In contrast, AI-ECG Tracker (Tool A) involves on-premise software and data download from a device, indicating a less streamlined user experience.

Clinical Value

EchoGo Pro

Both tools are FDA-cleared and demonstrate significant clinical value. While AI-ECG Tracker (Tool A) boasts over 95% accuracy for various ECG abnormalities and supports 104 diagnostic classifications, EchoGo Pro (Tool B) provides more specific and impactful metrics for its specialized application in stress echocardiography for CAD. It demonstrates a diagnostic performance of over 90% (AUROC) and a 10% improvement in sensitivity for CAD detection compared to clinicians' judgment alone.

Pricing & Value

EchoGo Pro

Neither tool provides publicly available pricing. However, EchoGo Pro (Tool B) explicitly mentions the availability of reimbursement codes for related EchoGo products, which offers a clearer understanding of its potential financial viability and value proposition for healthcare providers. This transparency around the reimbursement landscape gives Tool B a slight edge in this dimension.

Enterprise Readiness

EchoGo Pro

EchoGo Pro (Tool B) is explicitly HIPAA compliant and has a Business Associate Agreement (BAA), coupled with a cloud-based SaaS deployment, vendor-neutrality, and seamless integration with PACS, DICOM, and HL7. This makes it highly suitable for large-scale enterprise deployment. AI-ECG Tracker (Tool A) only states 'likely' HIPAA compliance and BAA, and its on-premise components may introduce more complex integration challenges.

Innovation

EchoGo Pro

Both tools leverage AI for cardiac diagnosis. However, EchoGo Pro (Tool B) demonstrates a higher degree of innovation by fully automating the complex and often subjective analysis of stress echocardiography for coronary artery disease, including extracting novel geometric and kinematic features and offering a 'zero-click, full automation workflow'. This addresses a more challenging diagnostic domain compared to the general ECG auto-diagnosis offered by AI-ECG Tracker (Tool A).

Support & Docs

Tie

Based on the provided information and web searches, both tools appear to offer relevant documentation. AI-ECG Tracker (Tool A) mentions an 'Operator Manual' and various certificates, while EchoGo Pro (Tool B) has 'Clinician User Manuals' and 'Technical Papers'. However, neither provides specific details about their support infrastructure (e.g., 24/7 availability, online portals, phone support), making it difficult to distinguish a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-ECG Tracker	EchoGo Pro
Name	AI-ECG Tracker	EchoGo Pro
Company	Shenzhen Carewell Electronics Co.	Ultromics
Primary Analysis Type	AI-powered ECG auto-analysis and diagnosis	AI-powered automated echocardiogram analysis
Key Diagnostic Focus	common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction	coronary artery disease (CAD)
Analysis Speed	Rapid diagnosis in approximately 3 seconds	near-instant, comprehensive reports

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Tracker and EchoGo Pro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary diagnostic applications of each AI tool?

AI-ECG Tracker focuses on AI-powered auto-analysis and diagnosis of 12-lead ECG data for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. EchoGo Pro specializes in AI-powered automated stress echocardiography analysis to improve the diagnosis of coronary artery disease (CAD).

Which specific cardiac conditions can each AI tool assist in diagnosing?

AI-ECG Tracker provides comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications, covering conditions like arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. EchoGo Pro is specifically designed for the automated identification and improved diagnostic accuracy of coronary artery disease (CAD) through stress echocardiography.

How quickly can I expect to receive results from each system?

AI-ECG Tracker provides rapid diagnosis in approximately 3 seconds for ECG auto-analysis. EchoGo Pro offers near-instant, comprehensive reports for automated echocardiogram analysis.

Are there any considerations regarding reimbursement for using these AI tools?

For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure in outpatient settings and NTAP XXE2X19 for inpatient settings. While AI-ECG technology has received CMS reimbursement for certain AI-ECG assessments effective January 1, 2025, specific reimbursement details for the AI-ECG Tracker product are not publicly available.

How do these tools integrate with existing clinical workflows and systems?

AI-ECG Tracker utilizes a Windows-based professional ECG diagnostic client and a web-based management portal, supporting 12-lead ECG data collection. EchoGo Pro is a vendor-neutral system designed for seamless integration with existing clinical workflows through DICOM and HL7, compatible with any PACS.